Latest Advances

  • Condition: Choroidal Neovascularization
  • Journal: Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti
  • Treatment Used: Ranibizumab
  • Number of Patients: 21
  • Published —
This study tested the safety and efficacy of using ranibizumab to treat patients with choroidal neovascularization.
  • Condition: Stargardt Macular Dystrophy
  • Journal: Nutrients
  • Treatment Used: Saffron Supplements
  • Number of Patients: 31
  • Published —
The purpose of this study was to evaluate the effectiveness of saffron in improving the function of the central retina of the eye in patients suffering from Stangardt macular dystrophy.
  • Condition: Dry-Type Age-Related Macular Degeneration (AMD) and Stargardt's Macular Dystrophy (SMD)
  • Journal: Cellular reprogramming
  • Treatment Used: Suprachoroidal Adipose Tissue-Derived Mesenchymal Stem Cell (ADMSC) Implantation
  • Number of Patients: 8
  • Published —
This study investigated the safety and effectiveness of suprachoroidal adipose tissue-derived mesenchymal stem cell (ADMSC) implantation in patients with dry-type age-related macular degeneration (AMD) and Stargardt's macular dystrophy (SMD).
  • Condition: Spinocerebellar ataxia type 2
  • Journal: Movement disorders : official journal of the Movement Disorder Society
  • Treatment Used: Neurorehabilitation therapy
  • Number of Patients: 38
  • Published —
The study researched the effects of neurorehabilitation therapy for spinocerebellar ataxia type 2.
  • Condition: Autosomal Recessive Stargardt Macular Dystrophy
  • Journal: Ophthalmic genetics
  • Treatment Used: Docosahexaenoic Acid (DHA) Supplementation
  • Number of Patients: 11
  • Published —
This study tested the effect of docosahexanoic acid (DHA) dietary supplementation on macular function in patients with Stargardt disease (a genetic eye disorder that causes progressive vision loss).
  • Condition: Macular Degeneration
  • Journal: Ophthalmology
  • Treatment Used: Transplantation of Human Embryonic Stem Cell(hESC)-Derived Retinal Pigment Epithelial (RPE) Cells
  • Number of Patients: 12
  • Published —
This study evaluated the safety and tolerability of human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells administration in the treatment of macular degeneration.
Showing 1-6 of 6